↓ Skip to main content

An open prospective study of amikacin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration

Overview of attention for article published in BMC Pharmacology and Toxicology, November 2012
Altmetric Badge

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
40 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
An open prospective study of amikacin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration
Published in
BMC Pharmacology and Toxicology, November 2012
DOI 10.1186/2050-6511-13-14
Pubmed ID
Authors

Deirdre M D’Arcy, Eoin Casey, Caitriona M Gowing, Maria B Donnelly, Owen I Corrigan

Abstract

The objectives of the current study were to determine amikacin pharmacokinetics in patients undergoing treatment with continuous venovenous haemodiafiltration (CVVHDF) in an Intensive Care Unit (ICU), and to determine whether peak and trough concentration data could be used to predict pharmacokinetic parameters. An open prospective study was undertaken, comprising five critically ill patients with sepsis requiring CVVHDF.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 2 5%
Japan 1 3%
Chile 1 3%
France 1 3%
Unknown 35 88%

Demographic breakdown

Readers by professional status Count As %
Other 8 20%
Researcher 6 15%
Student > Master 4 10%
Student > Bachelor 3 8%
Student > Doctoral Student 3 8%
Other 14 35%
Unknown 2 5%
Readers by discipline Count As %
Medicine and Dentistry 20 50%
Pharmacology, Toxicology and Pharmaceutical Science 9 23%
Agricultural and Biological Sciences 2 5%
Business, Management and Accounting 1 3%
Immunology and Microbiology 1 3%
Other 3 8%
Unknown 4 10%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 November 2012.
All research outputs
#10,074,195
of 13,185,699 outputs
Outputs from BMC Pharmacology and Toxicology
#181
of 269 outputs
Outputs of similar age
#96,977
of 144,981 outputs
Outputs of similar age from BMC Pharmacology and Toxicology
#14
of 16 outputs
Altmetric has tracked 13,185,699 research outputs across all sources so far. This one is in the 20th percentile – i.e., 20% of other outputs scored the same or lower than it.
So far Altmetric has tracked 269 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one is in the 27th percentile – i.e., 27% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 144,981 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.